| Dr Robert Gene Leikin, OD | |
|
2300 Dulaney Valley Rd, Timonium, MD 21093-2739 | |
| (410) 252-4500 | |
| (410) 560-9675 |
| Full Name | Dr Robert Gene Leikin |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 40 Years |
| Location | 2300 Dulaney Valley Rd, Timonium, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316051808 | NPI | - | NPPES |
| 401369700 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA0888 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Katzen Medical Associates Pc | 9436051232 | 26 |
News Archive
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease.
A team of physical therapy researchers from the University of Colorado School of Medicine have conducted one of the first full-scale studies to assess the effectiveness of in-home physical therapy care for patients who have had knee replacement surgery.
Natus Medical Incorporated today announced its financial guidance for the first quarter and full year 2011.
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial.
› Verified 7 days ago
| Provider Name | Katzen Medical Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326052614 PECOS PAC ID: 9436051232 Enrollment ID: O20040122000793 |
News Archive
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease.
A team of physical therapy researchers from the University of Colorado School of Medicine have conducted one of the first full-scale studies to assess the effectiveness of in-home physical therapy care for patients who have had knee replacement surgery.
Natus Medical Incorporated today announced its financial guidance for the first quarter and full year 2011.
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Gene Leikin, OD 19 Beecham Ct, Owings Mills, MD 21117-6001 Ph: (410) 654-8602 | Dr Robert Gene Leikin, OD 2300 Dulaney Valley Rd, Timonium, MD 21093-2739 Ph: (410) 252-4500 |
News Archive
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in advanced non-small cell lung cancer (NSCLC) that showed promising clinical activity in patients with progressive disease.
A team of physical therapy researchers from the University of Colorado School of Medicine have conducted one of the first full-scale studies to assess the effectiveness of in-home physical therapy care for patients who have had knee replacement surgery.
Natus Medical Incorporated today announced its financial guidance for the first quarter and full year 2011.
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial.
› Verified 7 days ago
Dr. Theodore Michael Walman, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 23 E Padonia Ave, Timonium, MD 21093 Phone: 410-667-1910 Fax: 410-667-1909 | |
Eye To Eye Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1819 York Rd, Timonium, MD 21093 Phone: 410-252-5850 Fax: 410-560-2165 | |
Dr A M Glasser Od And Associates Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1921 York Rd, Timonium, MD 21093 Phone: 410-561-5444 Fax: 410-561-0955 | |
Dr. Thomas Azman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2219 York Rd, Suite 101, Timonium, MD 21093 Phone: 410-561-8050 Fax: 410-561-8055 | |
Barnett Shpritz, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15 Texas Station Ct, Timonium, MD 21093 Phone: 410-628-7278 Fax: 410-628-6512 | |
Beverly Atueyi, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2391 Greenspring Dr, Timonium, MD 21093 Phone: 800-777-7904 |